Dr. Hazelton successfully defended his PhD thesis, “Engineering Probiotic Yeast for Targeted Oral Protein Delivery in IBD,” under the guidance of Dr. Juliane Nguyen!
Dr. Hazelton’s new position is a Postdoctoral Research Associate at UNC Chapel Hill.
Publications
Targeted and Quantitatively Modeled Biologic Delivery via Dual Functional Probiotic Yeast in Inflammatory Bowel Disease. Hazelton, A., et al., Nguyen, J. Journal of Controlled Release (2026). 2026 Apr 5;394:114906. https://doi.org/10.1016/j.jconrel.2026.114906. PMID: 41942055
Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis. Heavey, M.K., Hazelton, A., Wang, Y. Garner, M., Anselmo, A., Arthur, J., Nguyen, J. Nat Commun 15,3784 (2024). https://doi.org/10.1038/s41467-024-48128-0. PMID: 38710716. PMC11074276
Engineered Probiotic Saccharomyces boulardii Reduces Colitis-Associated Colorectal Cancer Burden in Mice. Culpepper, T., Senthil, K., Vlcek, J. Hazelton, A., Heavey, M.K., Sellers, R., Nguyen, J., Arthur, J. Dig Dis Sci (2025). https://doi.org/10.1007/s10620-025-09008-9. PMID: 40156662. PMC12301100
Shelf-stable, Ready-to-Use Therapeutic Patches: Dip-and-Deliver Solutions for Personalized Wound Care. Chaudhari, A., Tabashsum, Z., Khosravi, P., Hensley, H., Wang, C., Moses, E., Harris, S., Hazelton, A., et al. Bioengineering & Translational Medicine (2026). https://doi.org/10.1002/btm2.70131
Dr. Hazelton has another paper currently in press.
Honors, Awards & Highlights
Inclusive Excellence Top-Up (Fall 2021)
UNC NIH IMSD Grant (Fall 2021)
UNC NIH Pharmacological Sciences T32 (Summer 2022)
Ford Foundation Predoctoral Fellowship – Honorable Mention (Spring 2023)
DPMP Spring Poster Symposium – Honorable Mention (Spring 2024)
Best Oral Presentation Award, Pharmacology Research Retreat (Fall 2025)
